POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit [Accessibility Statement] Skip NavigationSan Diego, Feb. 24, 2026 /PRNewswire/ -- [Robbins LLP] reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic dis ...

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ostin Technology Group Co., Ltd. (NASDAQ: OST) ordinary shares between May 11, 2025 and June 26, 2025. OST purports to be a manufacturer of thin-film transistor liquid crystal display ("TFT-LCD") modules and polarizers used in consumer electronics, commercial LCD displays, and automotive displays. For more information, submit a form, email ...

Core Viewpoint - A class action lawsuit has been filed against Ostin Technology Group Co., Ltd. (NASDAQ: OST) for allegedly engaging in a pump-and-dump scheme that defrauded investors, resulting in significant financial losses [1]. Allegations - The lawsuit alleges that from April 2025, OST's co-CEO Lai Kui Sen and co-conspirators orchestrated a fraudulent sequence of securities offerings, placing the majority of OST shares in the hands of at least fifteen co-conspirators for minimal or no cost [1]. - The U.S. Department of Justice unsealed a criminal indictment on September 12, 2025, charging Lai Kui Sen and financial advisor Yan Zhao with conspiracy to commit securities fraud and wire fraud, with the scheme netting over $110 million in illicit proceeds [1]. - The fraudulent promotional campaign inflated OST's market capitalization from approximately $22 million (stock price of $0.78 on April 14, 2025) to over $1 billion (peak stock price of $9.40 on June 26, 2025) [1]. Financial Impact - On June 26, 2025, OST investors faced devastating losses, with over $950 million (more than 94%) of OST's market capitalization wiped out in a single day as the stock price plummeted from an intraday high of $9.40 to a closing price of $0.55 [1].

Core Viewpoint - A class action has been filed against China Liberal Education Holdings Ltd. for allegedly participating in a fraudulent pump-and-dump scheme that harmed investors by over $300 million [1][3]. Allegations - China Liberal Education Holdings Ltd. is accused of coordinating with scammers to manipulate the company's stock price through illegal means, including advertisements on social media platforms like Facebook and Instagram [2]. - Victims were recruited into WhatsApp groups where scammers posed as financial advisors, encouraging them to buy manipulated securities, allowing co-conspirators to sell at inflated prices [2]. Market Impact - The fraud was revealed on January 30, 2025, leading to an immediate collapse in the stock price, resulting in significant financial losses for investors [3]. Legal Proceedings - Shareholders interested in serving as lead plaintiffs in the class action have until March 31, 2026, to file their papers with the court [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Company Background - Robbins LLP is a law firm specializing in shareholder rights litigation, dedicated to helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - Scott+Scott Attorneys at Law LLP has filed a class action lawsuit against Picard Medical Inc. and several associated defendants, alleging violations of the Securities Exchange Act due to misleading statements and a fraudulent stock promotion scheme that led to significant losses for investors [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Northern District of California under the case name Louie v. Picard Medical, Inc. et al., with a lead plaintiff deadline set for April 3, 2026 [1][5]. - The class action targets individuals and entities that purchased Picard Medical Securities (PMI) between September 2, 2025, and October 31, 2025, who suffered damages as a result [1][4]. Group 2: Allegations Against Defendants - The complaint alleges that the defendants made materially false and misleading statements and failed to disclose adverse facts about Picard Medical's business and operations [3]. - It is claimed that the defendants orchestrated a "pump-and-dump" scheme, where the stock price was artificially inflated through a social media promotion involving impersonators posing as legitimate financial advisors [2][3]. Group 3: Company Overview - Picard Medical is involved in the design, manufacturing, and sale of medical devices, with its flagship product being the artificial heart "SynCardia TAH" [2]. - The company is headquartered in Tucson, Arizona, and operates in the United States, Europe, and China [2].

Core Viewpoint - A class action lawsuit has been filed against China Liberal Education Holdings, Ltd. for alleged securities fraud involving a "pump-and-dump" scheme that resulted in estimated losses exceeding $300 million [2][3]. Group 1: Lawsuit Details - The lawsuit, titled Atul Shah, et al. v. China Liberal Education Holdings Ltd., et al., was filed in the Southern District of New York and involves claims against the company's officers, directors, and associated service providers [1]. - The class period for the lawsuit is defined as January 22, 2025, to January 30, 2025, during which investors can seek appointment as lead plaintiff [1][3]. - The allegations include violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1]. Group 2: Investor Participation - Investors who purchased or acquired common stock of CLEU during the class period are eligible to seek lead plaintiff status but are not required to do so to participate in any future recovery [3]. - The plaintiffs intend to apply for lead plaintiff status and seek the appointment of Morris Kandinov LLP as lead counsel [3]. Group 3: Financial Implications - The alleged "pump-and-dump" scheme is said to have caused losses estimated to exceed $300 million, indicating significant financial implications for investors involved [2].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Fly-E Group, Inc. following a damaging report that led to a significant decline in the company's stock price [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of Fly-E Group, Inc. and is looking into whether the company and its officers or directors have engaged in securities fraud [1]. - The investigation was prompted by a report from The Bear Cave, which accused Fly-E of stock manipulation and being involved in a pump-and-dump scheme [3]. Group 2: Stock Performance - Following the publication of The Bear Cave report, Fly-E's stock price experienced a sharp decline over several consecutive trading sessions [3]. Group 3: Company Background - Fly-E Group, Inc. is under scrutiny for producing products that The Bear Cave claims endanger public safety in New York [3]. - Pomerantz LLP has a long history in corporate and securities class litigation, having recovered numerous multimillion-dollar damages awards for victims of securities fraud [4].